Previous Close | 0.5101 |
Open | 0.5200 |
Bid | 0.5088 x 1500 |
Ask | 0.5239 x 400 |
Day's Range | 0.5100 - 0.5700 |
52 Week Range | 0.2900 - 1.7800 |
Volume | |
Avg. Volume | 2,410,264 |
Market Cap | 108.085M |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
RICHMOND, Calif., March 13, 2024--Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results